Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Birault

Alain Birault, Paris FR

Patent application numberDescriptionPublished
20090056260Temperature Limit Switch - A thermal barrier includes a thermal insulating block, a layer of ultra-high performance fibered concrete integrated with the block, reinforcements embedded in the layer of ultra-high performance fibered concrete, the reinforcements protruding from the ultra-high performance fibered concrete on either side of the block. Embodiments of the invention further provides a building that includes the barrier, a process of manufacturing the barrier and a manufacturing process of the building.03-05-2009

Veronique Birault, Hertford GB

Patent application numberDescriptionPublished
20090105242Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases - Novel triazolopyridine compounds are disclosed that have a formula represented by the following:04-23-2009
20110092497IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES - Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following:04-21-2011

Patent applications by Veronique Birault, Hertford GB

Veronique Birault, Essex GB

Patent application numberDescriptionPublished
20090163515Compounds Which Bind to the Active Site of Protein Kinase Enzymes - The present invention relates to a compound and a group of compounds which are inhibitors of Rho kinase (ROK, ROCK). In addition, the invention relates to methods of treatment and use of the compounds in the manufacture of a medicament for application to a number of therapeutic indications including cardiovascular disease (coronary vasospasm, hypertensive disease, arteriosclerosis), stroke, cancer, erectile dysfunction, asthma, osteoporosis, glaucoma and AIDS. The compounds can be used in screening programmes against protein kinases. The invention also provides methods for making compounds and libraries that include these compounds.06-25-2009

Veronique Birault, Widdington GB

Patent application numberDescriptionPublished
20090029978THIENO-(1,3)-OXAZIN-4-ONES WITH LIPASE INHIBITING ACTIVITY - The use of a compound comprising formula (I), or a salt, ester, amide or prodrug thereof in the treatment of obesity and related disorders. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I): A is an optionally substituted thienyl moiety, Y is O, S, or NR01-29-2009